Publication | Open Access
Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial
386
Citations
19
References
2017
Year
Pharmalink AB.
| Year | Citations | |
|---|---|---|
Page 1
Page 1